Pages that link to "Q67937554"
Jump to navigation
Jump to search
The following pages link to New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results (Q67937554):
Displaying 4 items.
- Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors (Q39313203) (← links)
- A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies (Q40121414) (← links)
- Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa (Q40752008) (← links)
- Cytomegalovirus resistance in CD34 -selected hematopoietic cell transplant recipients. (Q52640678) (← links)